Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04236713
Other study ID # 7992
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 24, 2020
Est. completion date October 15, 2021

Study information

Verified date April 2020
Source McMaster University
Contact Natalia McInnes
Phone 905-521-2100
Email natalia.mcinnes@mcmaster.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The effects of food additives on body weight in humans are largely unknown. This is a feasibility study in 10 obese adults who will be followed for 5 months. Eligible participants will be non-randomly assigned to 2 groups and will be taught how to limit the exposure to the studied food additives in their diet. Primary outcomes in this study are recruitment rate, retention rate and adherence to the proposed dietary intervention.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date October 15, 2021
Est. primary completion date October 15, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- BMI >/=30 kg/m2

- willingness and ability to follow the proposed dietary interventions

- informed consent

Exclusion Criteria:

- previous or planned bariatric surgery in the next 1 year

- current or planned participation in any structured weight-loss programs in the next 6 months

- current or recent (within the last 6 months) use of weight-loss-inducing drugs or systemic steroids

- excessive alcohol consumption

- bipolar disorder or attention deficit hyperactivity disorder

- current use of anti-depressant or anti-psychotic medications

- eating disorder or any other active disorder that may lead to significant weight changes

- pregnancy or planned pregnancy in the next 1 year

- uncontrolled diabetes mellitus or diabetes requiring treatment with >2 oral diabetes medications or with insulin

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Dietary intervention 1
Limiting dietary exposure to ethylenediaminetetraacetic acid, erythorbate, propionate and related food additives; limiting eating out to a maximum of 2 days per week.
Dietary intervention 2
Limiting dietary exposure to nitrites, sulfites and related food additives; limiting eating out to a maximum of 2 days per week; limiting drinking wine to a maximum of 2 days per week.

Locations

Country Name City State
Canada McMaster University Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment rate Average number of participants recruited per month 0 months
Primary Retention rate in arm 1 Percent of enrolled participants who complete the study 5 months
Primary Retention rate in arm 2 Percent of enrolled participants who complete the study 5 months
Primary Adherence to the dietary intervention in arm 1 Proportion of meals/beverages free of the studied food additives on 3 unannounced 24-hour dietary recalls 2 to 5 months
Primary Adherence to the dietary intervention in arm 2 Proportion of meals/beverages free of the studied food additives on 3 unannounced 24-hour dietary recalls 2 to 5 months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2